Plasma IAPP-Autoantibody Levels in Alzheimer’s Disease Patients Are Affected by <i>APOE4</i> Status
Pancreas-derived islet amyloid polypeptide (IAPP) crosses the blood–brain barrier and co-deposits with amyloid beta (Aβ) in brains of type 2 diabetes (T2D) and Alzheimer’s disease (AD) patients. Depositions might be related to the circulating IAPP levels, but it warrants further investigation. Autoa...
Main Authors: | Dovilė Pocevičiūtė, Bodil Roth, Nina Schultz, Cristina Nuñez-Diaz, Shorena Janelidze, The Netherlands Brain Bank, Anders Olofsson, Oskar Hansson, Malin Wennström |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/4/3776 |
Similar Items
-
Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide
by: Cristina Nuñez-Diaz, et al.
Published: (2023-02-01) -
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
by: Dovilė Pocevičiūtė, et al.
Published: (2022-08-01) -
Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01) -
The Role of Glycation on the Aggregation Properties of IAPP
by: Giulia Milordini, et al.
Published: (2020-06-01) -
Urolithin B: Two-way attack on IAPP proteotoxicity with implications for diabetes
by: Ana F. Raimundo, et al.
Published: (2022-12-01)